John D. Carmichael

Guidelines for Acromegaly Management: An Update

Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer

2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer

Clinical effectiveness and cost-effectiveness of pegvisomant for the treatment of acromegaly: a systematic review and economic evaluation

Acromegaly

Quantitative Measurement of IGF-I and Its Use in Diagnosing and Monitoring Treatment of Disorders of Growth Hormone Secretion

Somatostatin analogues in acromegaly and gastroenteropancreatic neuroendocrine tumours: past, present and future

Effectiveness of self- or partner-administration of an extended-release aqueous-gel formulation of lanreotide in lanreotide-naïve patients with acromegaly

Long-Term Safety of Pegvisomant in Patients with Acromegaly: Comprehensive Review of 1288 Subjects in ACROSTUDY

Acromegaly pathogenesis and treatment

Ipilimumab treatment associated pituitary hypophysitis: Clinical presentation and imaging diagnosis

Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline

Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review

Clinical implications of growth hormone–secreting tumor subtypes

The JAK/STAT signaling pathway: from bench to clinic

The current status of IGF-I assays – A 2009 update

Acromegaly: An Endocrine Society Clinical Practice Guideline

Combined treatment for acromegaly with long-acting somatostatin analogs and pegvisomant: long-term safety for up to 4.5 years (median 2.2 years) of follow-up in 86 patients

The changing face of acromegaly—advances in diagnosis and treatment

Monitoring of acromegaly: what should be performed when GH and IGF‐1 levels are discrepant?

Pegvisomant Treatment in Acromegaly

Lower growth hormone and higher cortisol are associated with greater visceral adiposity, intramyocellular lipids, and insulin resistance in overweight girls

Endogenous Steroid Hormone Concentrations and Risk of Breast Cancer Among Premenopausal Women

Pathophysiology of Human Visceral Obesity: An Update

Reproducibility of Plasma Steroid Hormones, Prolactin, and Insulin-like Growth Factor Levels among Premenopausal Women over a 2- to 3-Year Period

A Consensus on Criteria for Cure of Acromegaly

Approach to the Patient with Persistent Acromegaly after Pituitary Surgery

Infection Due to Corynebacterium Species in Marrow Transplant Patients

Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States

Guidelines for Perioperative Care in Elective Rectal/Pelvic Surgery: Enhanced Recovery After Surgery (ERAS^®) Society Recommendations

American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Acromegaly-2011 Update

Clinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1)

The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism

Consensus Statement on the Standardization and Evaluation of Growth Hormone and Insulin-like Growth Factor Assays

The Utility of Oral Glucose Tolerance Testing for Diagnosis and Assessment of Treatment Outcomes in 166 Patients with Acromegaly

Update on the diagnosis and management of hypophysitis

GH peak response to GHRH‐arginine: relationship to insulin resistance and other cardiovascular risk factors in a population of adults aged 50–90

Variability and Reliability of single Serum IGF-I Measurements: Impact on Determining Predictability of Risk Ratios in Disease Development

American Society of Microbiology

Acromegaly Clinical Trial Methodology Impact on Reported Biochemical Efficacy Rates of Somatostatin Receptor Ligand Treatments: A Meta-Analysis

Lipodystrophy in Patients with Acromegaly Receiving Pegvisomant